Intelligence · Clinical Pipeline
R&D Pipeline Programs
ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.
- Programs indexed
- 20,548
- Companies
- 1,769
- Drugs tracked
- 4,797
Quick answer
NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.
-
anti-PD-1 / PD-L1 monoclonal antibody and chemotherapy
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Effect Increased
1 trial -
anti-Thyroid Drugs
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Graves Disease
1 trial -
antihistamine(low dose) chlorpheniramine (Dexchlorpheniramine maleate)
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Pain
1 trial -
avatrombopag
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Refractory Aplastic Anemia
1 trial -
bitter melon peptides
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Diabetes
1 trial -
bovine Lactoferrin
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Nosocomial Infections
1 trial -
caFFR
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Coronary Artery Disease
1 trial -
carbohydrates
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Insulin Resistance
1 trial -
cefditoren pivoxil tablets
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Medication Safety
1 trial -
chemotherapy plus TCM 1&ICIs plusTCM2
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Lung Cancer
1 trial -
cipher prescription 1
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Percutaneous Coronary Artery Intervention
1 trial -
circulating tumor cells test
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Thyroid Nodule
1 trial -
cisatracurium
Xiyuan Hospital of China Academy of Chinese Medical Sciences
ARDS
1 trial -
concentrated growth factor + bone substitute
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Concentrated Growth Factor
1 trial -
dexmedetomidine
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Anesthesia
1 trial -
diet management strategy for encephalopathy
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Hepatic Encephalopathy
1 trial -
etomidate anesthesia
Xiyuan Hospital of China Academy of Chinese Medical Sciences
General Anesthesia
1 trial -
folic acid
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Neural Tube Defects - Spina Bifida and Anencephaly
1 trial -
hAECs
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Premature Ovarian Failure
1 trial -
high protein
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Life Quality
1 trial -
insulin aspart
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Type 2 Diabetes Mellitus
1 trial -
intranasal oxytocin
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Healthy
7 trials -
intranasal oxytocin
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Learning Disabilities
1 trial -
iodine-containg spareribs soup
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Iodine Bioavailability
1 trial
Frequently asked questions
What is the NovaPharmaNews pipeline directory?
It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.
Where does pipeline data come from?
Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.
How do I find pipeline programs by company or phase?
Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.
Data attribution and licensing: Data sources